HOME >> BIOLOGY >> NEWS
New strategy for treating allergic disorders

Ghent − Oral intake of allergens or auto-antigens via the lactic acid bacterium Lactococcus lactis might be a new strategy for treating various kinds of auto-immune and allergic disorders. VIB researchers associated with Ghent University, in collaboration with the Academic Medical Center (AMC) in Amsterdam, have shown that auto-antigens or allergens can be administered orally via the lactic acid bacterium. Based on this principle, which has been patented by VIB, ActoGeniX − a spin-off from VIB and Ghent University − is already developing a variety of biopharmaceutical medicines for a range of clinical indications.

The immune system

Every day our immune system combats harmful substances and micro-organisms that seek to penetrate our body. However, if our immune system is not working properly, we are subject to a variety of diseases. In the case of auto-immune diseases, the immune system no longer distinguishes between our bodys own substances and foreign substances and begins to attack our own tissues and organs. In other cases, the immune system responds mistakenly to harmless substances, such as the house dust mite, milk products, or pollen. This inappropriate immune system reaction to contact with such substances (allergens) is called an allergy. Today, 20% of the European population suffers from an allergy, which is twice as many sufferers compared to 15 years ago.

Lactococcus as supplier of remedies

In its natural form, the lactic acid bacterium (Lactococcus lactis) is a well-known food bacterium that has been used since time immemorial to convert milk into cheese and yoghurt. In the battle against chronic intestinal diseases, VIB researchers have been using L. lactis as a producer of a drug against gastroenteritis. The initial results of the clinical trials are promising.

Now, the bacterium is also being used to fight other disorders. There are a number of active substances for the treat
'"/>

Contact: Ann Van Gysel
ann.vangysel@vib.be
329-244-6611
VIB, Flanders Interuniversity Institute of Biotechnology
1-Aug-2007


Page: 1 2

Related biology news :

1. Does EPA have an adequate strategy to oversee nanotechnologies?
2. High blood pressure medication strategy proves effective in Hispanic women
3. Rutgers: GM/GMO/Biotech crop containment strategy
4. Scientists identify new strategy for preventing acute and chronic brain disease
5. International risk research strategy and funding needed for nanotech safety
6. Study shows metabolic strategy of stressed cell
7. Trojan horse strategy defeats drug-resistant bacteria
8. Targeting the adrenal gland could be key strategy against heart failure, Jefferson scientists show
9. Drug strategy makes cancer genes get lost in translation
10. Researchers develop new strategy for the treatment of CML
11. Nanotech safety needs specific government risk research strategy and funding

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/9/2018)... ... August 08, 2018 , ... Specialty Med ... helps physicians bring the latest regenerative therapies and treatment options to their patients, ... 2018 in White Plains, NY. , The 2-day clinical collaboration ...
(Date:8/7/2018)... ... August 06, 2018 , ... BioMedGPS announces the launch ... Inspired by its medical device customers, BioMedGPS teamed up with a usability expert ... changes, SmartTRAK 3.0 touts a cleaner look, easier navigation and improved functionality. ...
(Date:8/2/2018)... , ... August 02, 2018 , ... ... solutions to pharmaceutical and biotech companies, today announced that Mark Jara, principal of ... inspiring people in the life sciences industry. Individuals named to PharmaVOICE 100 are ...
Breaking Biology News(10 mins):
(Date:8/14/2018)... ... August 14, 2018 , ... The growing interest in ... the Chinese Association of Orthopaedic Surgeons (CAOS) held in partnership with the North ... , Beijing, and Invibio Biomaterial Solutions partnered to demonstrate the new ...
(Date:8/9/2018)... ... August 08, 2018 , ... InTouchMD , the leading provider ... they will be exhibiting at Biotech Week Boston , September 4th – 7th ... Pulse platform, healthcare’s most powerful all in one marketing solution. Pulse is ...
(Date:8/9/2018)... ... August 09, 2018 , ... Simpson Gumpertz ... (AEC) experts with building owners and managers for a full-day discussion on health ... symposium comes to Boston for the first time on Thursday, 13 September 2018, ...
(Date:7/31/2018)... ... July 31, 2018 , ... Leading ... covers methods for extracting and using adipose tissue-derived stem cells to treat or ... While this patent covers Canada specifically, VetStem has been issued similar patents ...
Breaking Biology Technology:
Cached News: